08329.HK
Shenzhen Neptunus Interlong Bio-technique Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 0.10
−6.67%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.22x
- Price / sales
- 0.13x
- Price / cash flow
- 0.97x
Enterprise value
- Enterprise value
- HKD 93.9M
- EV / sales
- 0.07x
- EV / EBITDA
- 1.66x
- EV / EBIT
- -1.50x
- Market cap
- HKD 164.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026